Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome.

× No keyword cloud information.

7 in total

1. Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons.

Authors: K D García; M Mynlieff; D B Sanders; K G Beam; J P Walrond
Journal: Proc Natl Acad Sci U S A Date: 1996-08-20 Impact factor: 11.205

2. Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals.

Authors: R E Westenbroek; L Hoskins; W A Catterall
Journal: J Neurosci Date: 1998-08-15 Impact factor: 6.167

3. Altered properties of quantal neurotransmitter release at endplates of mice lacking P/Q-type Ca2+ channels.

Authors: Francisco J Urbano; Erika S Piedras-Rentería; Kisun Jun; Hee-Sup Shin; Osvaldo D Uchitel; Richard W Tsien
Journal: Proc Natl Acad Sci U S A Date: 2003-03-06 Impact factor: 11.205

4. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.

Authors: K L Engisch; M M Rich; N Cook; M C Nowycky
Journal: J Neurosci Date: 1999-05-01 Impact factor: 6.167

Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome.

1. Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons.

2. Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals.

3. Altered properties of quantal neurotransmitter release at endplates of mice lacking P/Q-type Ca2+ channels.

4. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.

Review 5. 3,4-Diaminopyridine, an orphan drug, in the symptomatic treatment of Lambert-Eaton myasthenic syndrome.

Review 6. Presynaptic calcium channels: specialized control of synaptic neurotransmitter release.

7. Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome.